Mesencephalic astrocyte-derived neurotrophic factor suppresses ferroptosis to alleviate depressive-like behaviors via the PERK/ATF4 signaling pathway
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Ferroptosis is being increasingly implicated in the pathophysiology of major depressive disorder (MDD). Endoplasmic reticulum (ER) stress is closely linked to ferroptosis, yet the endogenous regulators connecting ER dysfunction to ferroptosis during chronic stress remain unclear. Here, we report that the expression of mesencephalic astrocyte-derived neurotrophic factor (MANF), an ER stress-inducible protein, was upregulated in the hippocampus (Hip) of male mice subjected to chronic social defeat stress (CSDS). Hippocampal MANF overexpression alleviated depressive-like behaviors and suppressed ferroptosis, whereas MANF knockdown promoted stress susceptibility and facilitated ferroptosis. Ferrostatin-1 (Fer-1) mimicked the protective effects of MANF overexpression and rescued MANF deficiency-induced phenotypes. Mechanistically, MANF inhibited PERK/ATF4 signaling, and overexpression of PERK or ATF4 partially counteracted MANF-mediated protection, whereas their knockdown rescued MANF deficiency-induced phenotypes. Furthermore, ATF4 increased the promoter activity of glutathione-specific γ-glutamylcyclotransferase 1 (CHAC1) in an ATF4-binding-site-dependent manner, thereby impairing the SLC7A11/GPX4 anti-ferroptotic defense axis and driving ferroptosis. These findings identify hippocampal MANF as an endogenous protective factor that suppresses stress-induced ferroptosis through the PERK/ATF4 pathway and position MANF as a potential therapeutic target for MDD.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Mesencephalic astrocyte-derived neurotrophic factor suppresses ferroptosis to alleviate depressive-like behaviors via the PERK/ATF4 signaling pathway
- Date Crossref
- 01/10/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
The Affiliated Yongchuan Hospital of Chongqing Medical University pays non établi dans la noticeÉtablissement de santé
-
Chongqing Medical University Department of Psychiatry pays non établi dans la noticeUniversité ou école supérieure
-
Chongqing Institute for Brain and Intelligence pays non établi dans la noticeOrganisation à but non lucratif
-
Jinfeng Laboratory pays non établi dans la noticeStructure de recherche
The Affiliated Yongchuan Hospital of Chongqing Medical University, Department of Psychiatry — Chongqing Medical University et Chongqing Institute for Brain and Intelligence, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.